Do not change your dose without talking to your doctor first. When it is time to throw away the pump, safely throw away used AndroGel 1.62% in household trash. Let the gel dry before smoking or going near an open flame. To prime the AndroGel 1.62% pump, slowly push the pump all the way down 3 times. Before using a new bottle of AndroGel 1.62% for the first time, you will need to prime the pump.
Women who are pregnant should avoid contact with the area of skin where ANDROGEL 1.62% has been applied. Children and women should avoid contact with the unwashed or not covered (unclothed) areas where ANDROGEL 1.62% has been applied to your skin. ANDROGEL®(AN DROW JEL)(testosterone gel) 1.62% for topical use Figure 4 summarizes the mean total testosterone profile for these patients on Day 364.
This may not be a complete list of medicines that can interact with topical testosterone. In particular, make sure that you discuss if you are using any of the following before using topical testosterone. Always tell your health care provider about any prescription or over-the-counter (OTC) medicines, vitamins/minerals, herbal products, and other supplements you are using. It is unknown if drinking alcohol will affect topical testosterone.
All patients were started at a daily dose of 40.5 mg (two pump actuations) AndroGel 1.62% or matching placebo on Day 1 of the study. For 7 days, moisturizing lotion or sunscreen (SPF 50) was applied daily to the AndroGel 1.62% application site 1 hour after the application of AndroGel 1.62% 40.5 mg. On the 7th day of each treatment period, hypogonadal men took a shower with soap and water at either 2, 6, or 10 hours after drug application. After direct skin-to-skin contact with the site of application, mean testosterone Cavg and Cmax in female subjects increased by 280% and 267%, respectively, compared to mean baseline testosterone concentrations.
Misusing topical testosterone can lead to serious side effects, such as heart problems or mental health problems. Keep all appointments with your health care provider so they can monitor you while you are using topical testosterone. Women accidentally exposed to this medication may have side effects due to testosterone gel. This leaflet does not take the place of talking to your healthcare provider about your medical condition or treatment. Call your healthcare provider right away if you have any of the serious side effects listed above. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Stop using ANDROGEL 1.62% and call your healthcare provider right away if you see any signs and symptoms in a child or a woman that may have happened through accidental touching of the area where you have applied ANDROGEL 1.62%.
AndroGel 1.62% is used to treat adult males who have low or no testosterone due to certain medical conditions. AndroGel 1.62% is a prescription medicine that contains testosterone. The AndroGel 1% pump is no longer being manufactured.
The first phase was a multi-center, randomized, double-blind, parallel-group, placebo-controlled period of 182 days, in which 234 hypogonadal men were treated with AndroGel 1.62% and 40 received placebo. AndroGel 1.62% was evaluated in a two-phase, 364-day, controlled clinical study. AndroGel 1.62% is also supplied in unit-dose aluminum foil packets in cartons of 30. The pumps are composed of plastic and stainless steel and an LDPE/aluminum foil inner liner encased in rigid plastic with a polypropylene cap.
ANDROGEL 1.62% can transfer from your body to others including, children and women. The mean estradiol and DHT concentration profiles paralleled the changes observed in testosterone. Dose titrations on Days 14, 28, and 42 resulted in final doses of 20.25 mg â€" 81 mg on Day 112 as shown in Table 6. The percentages of patients with Cmax greater than 1500 ng/dL, and between 1800 and 2499 ng/dL on Day 112 were 11.2% and 5.5%, respectively. The secondary endpoint was the percentage of patients, with Cmax above three pre-determined limits. In patients treated with AndroGel 1.62%, 81.6% (146/179) had Cavg within the normal range at Day 112. The gauze pads were then analyzed for residual testosterone content.

Género: Hembra

Vínculos sociales